Bliss GVS Pharma Share Price
Know More₹174.35-3.15 (-1.77%)
04:01 PM, 24-Dec-2025₹175.92-3.08 (-1.72%)
03:50 PM, 24-Dec-2025BSE : 506197
NSE : BLISSGVS
Sector : Health care
ISIN Code : INE416D01022
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 24-Dec-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 1,845 |
Traded Value (₹ Cr) | 1.32 |
Volume (Shares) | 75,722 |
Face Value (₹) | 1 |
52-Week High (₹) | 190.65 |
52-Week High Date | 31-Jul-2025 |
52-Week Low (₹) | 105.05 |
52-Week Low Date | 09-May-2025 |
All Time High (₹) | 230.00 |
All Time High Date | 02-Jan-2018 |
All Time Low (₹) | 0.04 |
All Time Low Date | 07-Apr-1997 |
Bliss GVS Pharma Ltd
Market News
Bliss GVS Pharma Announcement
Bliss GVS Pharma Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,861 |
| EPS - TTM (₹) [C] | 10.91 |
| P/E Ratio (X) [C] | 16.12 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 50.00 |
| Latest Dividend Date | 24-Jul-2025 |
| Dividend Yield (%) | 0.28 |
| Book Value Share (₹) [C] | 107.04 |
| P/B Ratio (₹) [C] | 1.64 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.03 | 1,815 | 0.08 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 863 | 0.08 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 863 | 0.08 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 171.70 180.25 |
| Week Low/High (₹) | 143.15 184.00 |
| Month Low/High (₹) | 140.80 184.00 |
| Year Low/High (₹) | 108.12 191.00 |
| All time Low/High (₹) | 0.04 221.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 21.53% | 21.49% | 1.00% | 1.25% |
| 1 Month | 3.76% | 3.83% | 0.60% | 0.70% |
| 3 Month | 16.20% | 16.07% | 4.52% | 4.33% |
| 6 Month | 18.38% | 18.31% | 4.09% | 4.38% |
| 1 Year | 10.02% | 10.01% | 8.84% | 10.18% |
| 3 Year | 145.18% | 145.36% | 42.72% | 46.81% |
Company Info
Company Information
Whole-time Director : Vibha G Sharma
Whole-time Director : Shruti Vishal Rao
Non Executive & Independent Director : Santosh Parab
Company Sec. & Compli. Officer : Aditi Bhatt
Non Executive & Independent Director : Shilpa Bhatia
Managing Director : Gagan Harsh Sharmma
Chairman & Independent Director : Nandkumar Kashinath Chodankar
Registered Office: 102 Hyde Park Sakivihar Road, Andheri East,Mumbai,Maharashtra-400072 Ph: 91-22-42160000
FAQs about Bliss GVS Pharma Ltd
1. What's the Bliss GVS Pharma Ltd share price today?
Bliss GVS Pharma Ltd share price was Rs 174.35 at 04:01 PM IST on 24th Dec 2025. Bliss GVS Pharma Ltd share price was down by 1.77% from the previous closing price of Rs 177.50. Bliss GVS Pharma Ltd share price trend:
- Last 1 Month: Bliss GVS Pharma Ltd share price moved up by 3.76% on BSE.
- Last 3 Months: Bliss GVS Pharma Ltd share price moved up by 16.20% on BSE.
- Last 12 Months: Bliss GVS Pharma Ltd share price moved up by 10.02% on BSE.
- Last 3 Years: Bliss GVS Pharma Ltd share price moved up by 145.18% on BSE.
2. How can I quickly analyse the performance of the Bliss GVS Pharma Ltd stock?
The performance of the Bliss GVS Pharma Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 16.12
- Price to book value ratio is 1.64
- Dividend yield of 0.28
- The EPS (trailing 12 months) of the Bliss GVS Pharma Ltd stock is Rs 10.91
3. What is the market cap of Bliss GVS Pharma Ltd?
Bliss GVS Pharma Ltd has a market capitalisation of Rs 1,845 crore.
4. What is Bliss GVS Pharma Ltd's 52-week high/low share price?
The Bliss GVS Pharma Ltd’s 52-week high share price is Rs 190.65 and 52-week low share price is Rs 105.05.
5. Is the Bliss GVS Pharma Ltd profitable?
On a consolidated basis, Bliss GVS Pharma Ltd reported a profit of Rs 28.59 crore on a total income of Rs 264.58 crore for the quarter ended 2025.
6. Which are Bliss GVS Pharma Ltd’s peers in the Health care sector?
Bliss GVS Pharma Ltd’s top 5 peers in the Health care sector are Solara Active, Amrutanjan Healt, Novartis India, Bliss GVS Pharma, Windlas Biotech, Megasoft, Syncom Formul..
7. Who owns how much in Bliss GVS Pharma Ltd?
Key changes to the Bliss GVS Pharma Ltd shareholding are as follows:
- Promoter holding in Bliss GVS Pharma Ltd has gone up to 35.39 per cent as of Sep 2025 from 35.10 per cent as of Dec 2024.
